(Q64124528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

3 references

2 October 2020

29 January 2021

8 April 2021

Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

main subject

Maternal immunization

0 references

0 references

0 references

1 reference

2 October 2020

1 reference

29 January 2021

immunization programs

1 reference

8 April 2021

Sonali Kochhar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Alba Maria Ropero Alvarez

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Pedro L Moro

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

language of work or name

English

0 references

publication date

6 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

31 May 2019

3 references

2 October 2020

29 January 2021

8 April 2021

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

2 October 2020

29 January 2021

8 April 2021

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

page(s)

3267-3277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivatives

25 April 2020

copyright license

3 references

2 October 2020

29 January 2021

8 April 2021

Vaccines in pregnancy: The dual benefit for pregnant women and infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Vaccinations for pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Maternal immunisation: collaborating with mother nature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

A policy framework for accelerating adoption of new vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Introducing new vaccines in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Maternal immunization in Argentina: A storyline from the prospective of a middle income country

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Influenza immunization of pregnant women in resource-constrained countries: an update for funding and implementation decisions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

The quality-coverage gap in antenatal care: toward better measurement of effective coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

A New Look at Care in Pregnancy: Simple, Effective Interventions for Neglected Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Influenza immunization during pregnancy: Benefits for mother and infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

A global perspective of maternal influenza immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Considerations of strategies to provide influenza vaccine year round

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Improving rates of maternal immunization: Challenges and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Factors associated with a successful expansion of influenza vaccination among pregnant women in Nicaragua

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Off-label use of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Effect of package insert language on health-care providers' perceptions of influenza vaccination safety during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Safety assessment of immunization in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

A global survey of adverse event following immunization surveillance systems for pregnant women and their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Use of electronic immunization registry in the surveillance of adverse events following immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

A systematic review of adverse events following immunization during pregnancy and the newborn period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Ethics of maternal vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Maternal immunisation: ethical issues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Pertussis and influenza immunisation during pregnancy: a landscape review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Bacterial meningitis in the United States, 1998-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.04.075

Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005.

7 January 2021

1 reference

12 December 2020

Vaccines against influenza WHO position paper – November 2012

1 reference

12 December 2020

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

1 reference

12 December 2020

Vaccines and vaccination against yellow fever. WHO position paper -- June 2013

1 reference

12 December 2020

Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety

1 reference

12 December 2020

Pertussis vaccines: WHO position paper - September 2015

1 reference

12 December 2020

Tetanus vaccines: WHO position paper – February 2017

1 reference

12 December 2020

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.

1 reference

12 December 2020

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics.

1 reference

12 December 2020

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) Study of Respiratory Syncytial Virus-Associated Deaths in Pediatric Patients in Canada: 2003 to 2013.

1 reference

12 December 2020

Progress towards a comprehensive approach to maternal and neonatal immunization in the Americas

1 reference

12 December 2020

10.1016/J.VACCINE.2019.04.075

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31072733%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

PubMed publication ID

31072733

1 reference